Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease
- PMID: 8731708
- PMCID: PMC2398397
- DOI: 10.1136/pgmj.72.845.164
Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease
Abstract
The aetiology of weight loss in patients with Parkinson's disease is likely to be multifactorial. We studied 15 patients with Parkinson's disease and 15 age- and sex-matched controls and looked for evidence of malabsorption due to small bowel bacterial overgrowth or alteration of intestinal permeability. There was a marked increase in orocaecal transit time in the patients with Parkinson's disease, although lactulose hydrogen breath testing did not show evidence of small bowel bacterial contamination. Intestinal permeability measured by the differential sugar absorption test was also deranged. There was reduced absorption of mannitol in patients with Parkinson's disease while lactulose absorption was similar in both groups, suggesting decreased non-mediated uptake across the enterocyte brush border membrane in patients with Parkinson's disease.
Comment in
-
Gastrointestinal disorders in Parkinson's disease.Postgrad Med J. 1997 Oct;73(864):686. doi: 10.1136/pgmj.73.864.686-a. Postgrad Med J. 1997. PMID: 9497997 Free PMC article. No abstract available.
Similar articles
-
Small intestinal permeability and orocaecal transit time in cystic fibrosis.Arch Dis Child. 1990 Jun;65(6):585-8. doi: 10.1136/adc.65.6.585. Arch Dis Child. 1990. PMID: 2116115 Free PMC article.
-
Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.Hell J Nucl Med. 2016 May-Aug;19(2):124-9. doi: 10.1967/s002449910365. Epub 2016 Jun 22. Hell J Nucl Med. 2016. PMID: 27331205
-
Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.PLoS One. 2015 Dec 2;10(12):e0143690. doi: 10.1371/journal.pone.0143690. eCollection 2015. PLoS One. 2015. PMID: 26629926 Free PMC article. Clinical Trial.
-
Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function.Scand J Gastroenterol Suppl. 1997;223:70-8. Scand J Gastroenterol Suppl. 1997. PMID: 9200310 Review.
-
[Lactulose and the microecology of the large intestine].Zh Mikrobiol Epidemiol Immunobiol. 1998 Sep-Oct;(5):101-7. Zh Mikrobiol Epidemiol Immunobiol. 1998. PMID: 9825511 Review. Russian. No abstract available.
Cited by
-
Autonomic Dysfunction in Parkinson's Disease.Neurotherapeutics. 2020 Oct;17(4):1464-1479. doi: 10.1007/s13311-020-00897-4. Neurotherapeutics. 2020. PMID: 32789741 Free PMC article. Review.
-
The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.J Parkinsons Dis. 2019;9(s2):S323-S329. doi: 10.3233/JPD-191707. J Parkinsons Dis. 2019. PMID: 31561386 Free PMC article. Review.
-
Imaging the Autonomic Nervous System in Parkinson's Disease.Curr Neurol Neurosci Rep. 2018 Sep 19;18(11):79. doi: 10.1007/s11910-018-0889-4. Curr Neurol Neurosci Rep. 2018. PMID: 30232650 Review.
-
Paracellular permeability and tight junction regulation in gut health and disease.Nat Rev Gastroenterol Hepatol. 2023 Jul;20(7):417-432. doi: 10.1038/s41575-023-00766-3. Epub 2023 Apr 25. Nat Rev Gastroenterol Hepatol. 2023. PMID: 37186118 Free PMC article. Review.
-
Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis.Gut Pathog. 2021 Apr 16;13(1):25. doi: 10.1186/s13099-021-00420-w. Gut Pathog. 2021. PMID: 33863370 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical